| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2002 | US6365191 Formulation containing nanoparticles of polymeric micelles containing paclitaxel, derivative or analog thereof physically entrapped therein, also including alcohol, anionic surfactant, buffering agent and intravenous aqueous diluent |
| 04/02/2002 | US6365190 Preparing aqueous solution of hydrophilic component and organic solution of hydrophobic component, delivering solutions to atomizer separately, atomizing together to produce droplets containing both components, spray drying |
| 04/02/2002 | US6365188 Solid mixtures of cyclodextrins prepared via meltextrusion |
| 04/02/2002 | US6365186 Combination therapy for treating hypercholesterolemia |
| 04/02/2002 | US6365184 Multiple unit tableted dosage forms containing acid susceptible proton pump inhibitor in combination with one or more nsaids and wherein at least proton pump inhibitor is protected by enteric coated layer |
| 04/02/2002 | US6365180 Oral liquid compositions |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | US6365175 Petroselinic acid and its use in food |
| 04/02/2002 | US6365167 Treating wounds, lesions, lacerations, burns and ulcers in humans and animals by administering composition of reaction product of arginine and p-aminobenzoic acid |
| 04/02/2002 | US6365166 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1h-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | US6365145 Using liposome; applying light |
| 04/02/2002 | US6365138 Compositions for metabolic protection and repair of lips |
| 04/02/2002 | US6365134 Containing peroxide |
| 04/02/2002 | US6365131 Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
| 04/02/2002 | US6364907 Method to prevent xenograft transplant rejection |
| 04/02/2002 | CA2357961A1 Method for reduction of inflammation and erythema |
| 04/02/2002 | CA2357958A1 Method for promoting clear skin |
| 04/02/2002 | CA2357929A1 Nmda nr2b antagonists for the treatment of depression |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2233277C Stable extract of hypericum perforatum l., processes for its preparation and pharmaceutical compositions |
| 04/02/2002 | CA2213700C Pharmaceutical composition for piperidinoalkanol compounds |
| 04/02/2002 | CA2144047C Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
| 04/02/2002 | CA2101273C Arachidonic acid and methods for the production and use thereof |
| 04/02/2002 | CA2099868C Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 04/02/2002 | CA2083361C Fish production |
| 04/02/2002 | CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments |
| 04/02/2002 | CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it |
| 04/02/2002 | CA2053340C Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
| 04/02/2002 | CA2039909C Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 04/02/2002 | CA2035758C Antimycotic external imidazole preparations |
| 04/02/2002 | CA1341354C Anticoagulant peptide alcohols |
| 03/29/2002 | WO2003045398A1 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2002 | WO2002066039A1 Anticancer agent |
| 03/29/2002 | CA2357998A1 Composition to enhance permeation of topical skin agents |
| 03/29/2002 | CA2357450A1 Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis |
| 03/29/2002 | CA2322338A1 Triterpene saponins from soybeans for treating kidney disease |
| 03/29/2002 | CA2321406A1 Restoration of perturbed barrier function by application of antiandrogens |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002025194A1 Drying method for selectively removing volatile components from wet coatings |
| 03/28/2002 | WO2002024957A1 Methods and compositions for modulating angiogenesis |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024906A1 Induction of exon skipping in eukaryotic cells |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | WO2002024711A1 Novel thiazole bicyclic compounds |
| 03/28/2002 | WO2002024708A1 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| 03/28/2002 | WO2002024706A2 Water soluble rapamycin esters |
| 03/28/2002 | WO2002024705A1 Stereoselective process for preparing cyclohexyl amine derivatives |
| 03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024701A2 Substituted azepino[4,5b)indole derivatives |
| 03/28/2002 | WO2002024700A2 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2002024695A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
| 03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
| 03/28/2002 | WO2002024692A1 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 03/28/2002 | WO2002024691A1 Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides |
| 03/28/2002 | WO2002024690A2 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024685A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 03/28/2002 | WO2002024684A1 Quinoline derivatives as antibacterials |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024680A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024674A1 Benzoic acid derivatives and uses thereof |
| 03/28/2002 | WO2002024673A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024667A1 4-amino-quinazolines |
| 03/28/2002 | WO2002024666A2 4-amino-quinazolines |
| 03/28/2002 | WO2002024665A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024659A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
| 03/28/2002 | WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024657A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024655A1 Isoquinolinone potassium channel inhibitors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024652A1 Compounds and methods for diagnosing and treating amyloid-related conditions |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria |
| 03/28/2002 | WO2002024647A1 Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| 03/28/2002 | WO2002024646A1 Delta1-pyrrolines used as pesticides |
| 03/28/2002 | WO2002024639A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002024633A1 Phenylpropionic acid derivatives |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |